SBC Medical Group Holdings Incorporated (NASDAQ:SBC) Sees Large Growth in Short Interest

SBC Medical Group Holdings Incorporated (NASDAQ:SBC) was the recipient of a large increase in short interest in the month of December. As of December 31st, there was short interest totaling 401,307 shares, an increase of 179.2% from the December 15th total of 143,744 shares. Based on an average daily volume of 106,270 shares, the short-interest ratio is presently 3.8 days. Approximately 3.7% of the company’s shares are sold short. Approximately 3.7% of the company’s shares are sold short. Based on an average daily volume of 106,270 shares, the short-interest ratio is presently 3.8 days.

SBC Medical Group Stock Performance

Shares of NASDAQ SBC opened at $4.45 on Thursday. The firm’s 50-day moving average price is $3.91 and its 200-day moving average price is $4.19. SBC Medical Group has a 52-week low of $2.62 and a 52-week high of $7.00. The company has a market cap of $456.48 million, a PE ratio of 10.85 and a beta of 1.14. The company has a quick ratio of 5.06, a current ratio of 5.10 and a debt-to-equity ratio of 0.07.

SBC Medical Group (NASDAQ:SBC) last issued its earnings results on Friday, November 14th. The company reported $0.12 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.13 by ($0.01). The company had revenue of $43.35 million during the quarter, compared to analysts’ expectations of $46.45 million. SBC Medical Group had a return on equity of 24.17% and a net margin of 24.28%. As a group, analysts anticipate that SBC Medical Group will post 5.02 EPS for the current year.

Wall Street Analyst Weigh In

Several equities research analysts recently weighed in on the company. Weiss Ratings restated a “sell (d+)” rating on shares of SBC Medical Group in a research report on Monday, December 29th. Wall Street Zen upgraded SBC Medical Group from a “hold” rating to a “buy” rating in a research note on Saturday, September 20th. Finally, Maxim Group assumed coverage on SBC Medical Group in a report on Wednesday, November 5th. They set a “buy” rating and a $9.00 price target for the company. One research analyst has rated the stock with a Buy rating and one has given a Sell rating to the company. According to MarketBeat, the stock has an average rating of “Hold” and a consensus price target of $9.00.

Institutional Trading of SBC Medical Group

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in SBC. Geode Capital Management LLC purchased a new stake in shares of SBC Medical Group in the 2nd quarter worth $455,000. SBI Securities Co. Ltd. boosted its stake in shares of SBC Medical Group by 227.3% in the second quarter. SBI Securities Co. Ltd. now owns 54,177 shares of the company’s stock worth $251,000 after acquiring an additional 37,623 shares during the period. Millennium Management LLC bought a new stake in SBC Medical Group during the 3rd quarter valued at approximately $219,000. New York State Common Retirement Fund purchased a new position in SBC Medical Group in the 2nd quarter worth approximately $104,000. Finally, XTX Topco Ltd bought a new position in SBC Medical Group in the 2nd quarter worth approximately $64,000. 60.82% of the stock is owned by hedge funds and other institutional investors.

About SBC Medical Group

SBC Medical Group, Inc is a publicly traded healthcare management services company listed on the Nasdaq under the ticker SBC. The company specializes in supporting in-office ancillary service providers by offering a suite of administrative and operational solutions designed to streamline practice management and enhance revenue performance. Its core mission is to help physician practices, imaging centers and other ancillary service providers focus on patient care while outsourcing complex back-office functions.

The company’s primary offerings include revenue cycle management, medical billing and coding, compliance oversight and transcription services.